Pharmakon Compounding Pharmacy Pauses Production And Recalls Sterile Products.

reports that the Pharmakon compounding pharmacy in Noblesville, Indiana “has ceased production and recalled its sterile products after a federal investigation of its facilities.” Food and Drug Administration inspectors “investigated the Pharmakon facility after the company issued a voluntary recall in February for an intravenous form” of morphine sulfate which was linked to “serious adverse effects” in three infants. The FDA had “recommended that Pharmakon cease all sterile operations and recall its sterile products” last week, but Pharmakon had initially refused. http://www.indystar.com/story/news/2016/04/20/fda-asks-noblesville-pharmacy-pause-manufacturing/83245732/